$249 for CRN members / $399 for non-members
Registration closes October 15 at 10 am Eastern
Navigate evolving GRAS regulations and legislation with expert insights, risk strategies, and practical compliance guidance.
GRAS oversight is entering a period of significant change. FDA is expected to propose updates to the federal GRAS framework, while Congress and several states are advancing legislation that could reshape how ingredients are evaluated, marketed, and regulated. These developments have the potential to affect ingredient innovation, product development, compliance strategies, and business operations across the dietary supplement and functional food industry.
This half-day virtual workshop will help attendees understand what is changing, why it matters, and how to prepare. Expert speakers will examine the evolving federal and state landscape, explain the practical implications for dietary supplement companies, and discuss potential outcomes under different policy scenarios. Participants will gain actionable insights into emerging requirements, identify key risks and opportunities, and develop strategies to navigate a rapidly changing regulatory environment. Whether you are responsible for regulatory, scientific, legal, or business decisions, this program will equip you to anticipate change and respond with confidence.
Hear from:
Alex Eapen
Senior Director, R&D Scientific & Regulatory Affairs – North America, Cargill
Alex is the Senior Director of the Scientific & Regulatory Affairs Team – North America at Cargill. He has over 25 years of experience as a toxicologist and risk assessor for FDA-regulated products. Additionally, Alex is an adjunct faculty at the University of Minnesota College of Continuing and Professional studies. He serves on several scientific and trade organizations representing the food ingredient industry. He is a Diplomate of the American Board of Toxicology and a Fellow of the Academy of Toxicological Sciences.
Claire Kruger
Managing Partner, Spherix
Dr. Claire Kruger is a Managing Partner of Spherix Consulting Group, Inc. With more than 35 years of consulting experience, her primary area of expertise is in foods, dietary supplements and pharmaceuticals, where she provides scientific, regulatory, and strategic support to clients in both the US and international regulatory arenas. Dr. Kruger conducts risk assessments of food ingredients, food contaminants, dietary supplements and drugs, and applies the evaluations to regulatory submissions such as Generally Recognized As Safe Determinations, New Dietary Ingredient Notifications, Novel Food Petitions, and Investigational New Drug Applications. In addition, she has developed novel approaches for evaluating the safety of bioactive ingredients and complex extracts and has employed these approaches in completing GRAS determinations for novel bioactive functional ingredients. Dr. Kruger has served as an expert for many GRAS determinations. Her clients include food, drug, and dietary supplement manufacturers, agricultural producers, biotechnology companies, trade associations, and law firms. Prior to her current position, Dr. Kruger held positions as President of ChromaDex Spherix Consulting, CEO of Spherix Incorporated, and Principal at ENVIRON Corporation.
Tony Pavel
Partner, Keller and Heckman LLP
Anthony (Tony) Pavel is a partner at Keller and Heckman LLP, in Washington, DC. Tony guides clients through a comprehensive array of food and drug regulatory matters with his extensive knowledge of U.S. Food and Drug Administration (FDA) laws and regulations related to food, food additives and ingredients, and dietary supplements. Tony is a globally recognized expert on Food Law, whose advice and perspectives are sought by industry and legislators. Prior to joining Keller and Heckman, Tony was in private practice at a leading international law firm, followed by in-house positions leading Global Food Law at Cargill Incorporated, one of the world’s largest food, agricultural, and industrial products producers, and Deputy General Counsel, Global Food Law for Perfect Day, a billion dollar consumer biology startup that was the first company to commercialize a milk whey protein produced through fermentation. Tony’s in-house corporate experience helped shape his approach to practical, actionable advice and effective solutions for clients. Tony is frequently invited to speak at domestic and global conferences on food ingredients, food additives, and related policy matters.
$249 for CRN members / $399 for non-members
Registration closes October 15 at 10 am Eastern
